intro to neurostimulation asent feb 28 2013
TRANSCRIPT
Neurostimulation: An Overview
Thursday Feb 28th
Shaun Comfort, MD, MBA
Adaptix Clinical Solutions, LLC
American Society for Experimental NeuroTherapeutics | 15th Annual Meeting
Disclosure(s)
Consulting relationships with multiple Pharma, Bio, and Medical Device Companies
Equity: J&J
American Society for Experimental NeuroTherapeutics | 15th Annual Meeting
Other:
I will discuss some currently unapproved Rx/Research technologies
Learning Objectives
• Outline the context & history of Neurostimulation
• Identify several current Neurostim therapies
The Brave New World of Neurostimulation
American Society for Experimental NeuroTherapeutics | 15th Annual Meeting
Basic Definitions
• Fundamental Quantity: Charge = Coulomb
• Negative Charges: Electrons = 1.6 x 10-19 C
• Moving Charges: Current = Amp {C/sec}
• Charge Source (eg Battery): Voltage = Potential Energy/Ch = Volt {Joules/C}
• Useful Relation: Ohm’s Law V = iR
• Other Useful Terms:
• Frequency = Cycles/sec {Hertz}
American Society for Experimental NeuroTherapeutics | 15th Annual Meeting
Basic Definitions, cont
American Society for Experimental NeuroTherapeutics | 15th Annual Meeting
Neurostimulation?
• Neurostimulation? • The modulation of nervous system activity by
electrically activating individual or groups of neurons in the body, to achieve a clinical goal.
• Can be achieved using:
• Surface electrodes
• Implantable electrodes
• Indirect: Vector Force Fields (TMS)
American Society for Experimental NeuroTherapeutics | 15th Annual Meeting
Early Neurostimulation?
• First application of neurostimulation:
• Scribonius Largus, 65 AD
• Torpedo fish (electric ray)
• for relieving pain (Early TENS?)
• Empirical findings that electricity applied to skin had interesting effects such as pain reduction
American Society for Experimental NeuroTherapeutics | 15th Annual Meeting
Coincidental Physics
American Society for Experimental NeuroTherapeutics | 15th Annual Meeting
American Society for Experimental NeuroTherapeutics | 15th Annual Meeting
Faradization for Pain Relief
American Society for Experimental NeuroTherapeutics | 15th Annual Meeting
The Good Old Days?
• Early Faradization primitive and overly broad claims: • “Electreat” device – Willie Kent 1st
person prosecuted under FD&C (1938) for Unsubstantiated Claims
• Claims later limited to pain
• However, this approach evolved into Transcutaneous Electrical Stimulation (TENS) used today for pain (eg, Shealy MD & Medtronics, 1970s)
American Society for Experimental NeuroTherapeutics | 15th Annual Meeting
Beyond Peripheral Faradization
• Early 20th century - co-incident advances in electronics and medicine produced new tools for electrophysiology: ECG (1911), EEG (Berger, 1924) and therapy: ECT (Cerletti & Bini, 1938)
American Society for Experimental NeuroTherapeutics | 15th Annual Meeting
If That Is the Past, Where Are We Today?
• We are riding the 20th Century wave of Neuroscience + Moore’s Law
• The results are: • Implantable micro-electronics
• Open (VNS, DBS) - and Closed-loop (?) therapies
• Wireless monitoring (eg, Implanted EEG)
• Smart diagnostics (eg, ECG/EEG Interpretation)
• Rapid advances in Neurosurgery, fMRI, etc
American Society for Experimental NeuroTherapeutics | 15th Annual Meeting
Moore’s Law
To 1st approximation, doubling of transistor density & computing efficiency every 18 months
American Society for Experimental NeuroTherapeutics | 15th Annual Meeting
SCS, TENS, tDCS, etc
American Society for Experimental NeuroTherapeutics | 15th Annual Meeting
TENS, TMS, DBS, VNS, etc
American Society for Experimental NeuroTherapeutics | 15th Annual Meeting
American Society for Experimental NeuroTherapeutics | 15th Annual Meeting
NS Classification Grid
External Implanted
Peripheral NS • TENS - Pn
• CI – Aud • GES - GI • SNS - GU
Central NS
• ECT – Dep • TMS – Dep • TNS – HA • tDCS
• SCS – Pn • OI –Vis • VNS-Ep
• DBS-PD, Et, Ep
• CtS - Ep
Aud = Auditory; CI = Cochlear Implant; CtS = Cortical Stimulation; Dep = Depression; Ep = Epilepsy; Et = Essential Tremor; GI = Gastrointestinal; GNS = GastricElectric Stimulation; GU = Genitorurological; HA = Headache; OI = Occipital Implant;PD =
Parkinson’s Dz; Pn = Pain/Analgesia; SCS = Spinal Cord Stimulation; SNS = Sacral Nerve Stimulation; TNS = Trigeminal Nerve Stmulation; Vis = Vision
Current NS Treatment Modalities
What Are the Challenges?
• Clinical Trials: Demonstrating efficacy under placebo conditions difficult due to blinding & operator characteristics
• Long-term Stable Power Sources: Bigger batteries vs. recharging for implantables
• Closed Loop vs. Open Loop Methodologies
• Support: Implantable Neurostim looking much like pharma/biologic development: Time and $$$
Impact on Clinical Care and Practice • NS has a long history of use in medicine • NS is a useful adjunctive tool in the treatment of Neurologic conditions • Several therapies have proven efficacy and safety for various disease conditions (eg, ET, Epilepsy) • Much interest in new approaches:
• Implantable cortical and Deep Brain Stim for Epilepsy + other conditions • Non-invasive surface Trigeminal & Vagal Stimulation
• Clinical trials, development timelines can be challenging • NS is still maturing
References/Data/Graphic Sources
• tp://en.wikipedia.org/wiki/Electric_current • antenna-theory.com; Physlink.com, various Google Images • tp://www.burtonreport.com/infspine/NSHistNeurostimPar
tI.htm • thefullwiki.org;
http://en.wikipedia.org/wiki/Electroconvulsive_therapy and ../Electroencephalography
• http://www.economist.com/blogs/dailychart/2011/10/computing-power & letshavetheconversation.blogspot.com
• Osteoarthritis.about.com; Scientific American.com; http://www.burtonreport.com/infspine/NSHistNeurostimPartI.htm
• Osteoarthritis.about.com; Medtronic.com; Cyberonics.com